- Trials with a EudraCT protocol (421)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
421 result(s) found for: Acute Inflammation.
Displaying page 1 of 22.
EudraCT Number: 2014-000400-99 | Sponsor Protocol Number: PLMA34 | Start Date*: 2014-09-15 | |||||||||||
Sponsor Name:Radboud university medical center | |||||||||||||
Full Title: 10-day decitabine, fludarabine and 2 Gray TBI as conditioning strategy for poor and very poor risk AML in CR1 | |||||||||||||
Medical condition: Acute myeloid leukemia AML | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001589-13 | Sponsor Protocol Number: N/A | Start Date*: 2012-06-26 | |||||||||||
Sponsor Name:Belfast Health and Social Care Trust | |||||||||||||
Full Title: The effect of Aspirin on REducing iNflammation in human in vivo model of Acute lung injury (ARENA) | |||||||||||||
Medical condition: The intended indication for the product under development is that of acute lung injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004878-29 | Sponsor Protocol Number: NA | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:St. Antonius Hospital | |||||||||||||
Full Title: Perioperative antibiotic use in the treatment of acute calculous cholecystitis | |||||||||||||
Medical condition: Acute calculous cholecystitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004361-12 | Sponsor Protocol Number: FER-CIT-2016-01 | Start Date*: 2017-03-27 | ||||||||||||||||
Sponsor Name:Fernando Sánchez | ||||||||||||||||||
Full Title: Oxidative stress and extracellular nucleosomes in critically ill patients with acute kidney failure treated with continuous renal replacement therapies. Effect of two anticoagulation strategies of ... | ||||||||||||||||||
Medical condition: Acute renal failure (ARF). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002629-95 | Sponsor Protocol Number: 170188 | Start Date*: 2022-08-02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of vascular surgery, Lillebaelt Hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Cefuroxime and Piperacillin Concentrations in the Biliary System | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Infection in the biliary system such as cholecystitis and cholangitis both as acute infections and post-operative infections. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006220-19 | Sponsor Protocol Number: SUM-2006/01-INT | Start Date*: 2008-11-27 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:PLIVA Hrvatska d.o.o. | ||||||||||||||||||||||||||||||||||||||
Full Title: Safety and Efficacy of Sumamed® Therapy in the Treatment of Respiratory Tract Infections in Adults and Children: International, Multicenter, Non-Comparative Study | ||||||||||||||||||||||||||||||||||||||
Medical condition: acute pharyngitis/tonsilitis acute sinusitis acute otitis media acute exacerbation of chronic bronchitis community acquired pneumonia | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: SI (Completed) CZ (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005623-16 | Sponsor Protocol Number: OY122013 | Start Date*: 2014-03-20 | |||||||||||
Sponsor Name:Minna Honkila | |||||||||||||
Full Title: ANTIBIOTICS VERSUS PLACEBO FOR ACUTE BACTERIAL CONJUNCTIVITIS IN CHILDREN: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL | |||||||||||||
Medical condition: Acute conjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002454-37 | Sponsor Protocol Number: RGHT000392 | Start Date*: 2007-07-20 |
Sponsor Name:The Royal Group Hospitals Trust | ||
Full Title: Prevention by HMGCoA reductase inhibition of ALI associated with one lung ventilation following oesophagectomy by a Reduction of Pulmonary vascular dysfunction and inflammation (Prevention-HARP) | ||
Medical condition: Acute lung injury (ALI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002779-34 | Sponsor Protocol Number: BAY 12-8039/11881 | Start Date*: 2005-12-13 | |||||||||||
Sponsor Name:BAYER | |||||||||||||
Full Title: Prospective, multicenter, randomized, double blind, parallel arm study to evaluate the efficacy and safety of Moxifloxacin 400 mg OD for 7 days versus amoxicillin clavulanate/claritromycin for 10 d... | |||||||||||||
Medical condition: Acute bacterial rhinosinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000641-39 | Sponsor Protocol Number: C-05-37 | Start Date*: 2018-04-05 | |||||||||||
Sponsor Name:Alcon Research Ltd | |||||||||||||
Full Title: Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Externa (AOE) | |||||||||||||
Medical condition: Acute Otitis externa | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002638-35 | Sponsor Protocol Number: 3.00 | Start Date*: 2012-07-31 |
Sponsor Name:Stockholms Läns Landsting, Karolinska Universitetssjukhuset Huddinge, Anestesikliniken | ||
Full Title: ALBUMIN KINETICS BY 123I-HSA A validation study on healthy volunteers, patients with acute inflammation, and patiens scheduled for major abdominal surgery | ||
Medical condition: A) healthy volunteers (transcapillary escape rate of albumin, plasmavolume, and turnover of albumin) B) Acute inflammation such as pancreatitis or cholecystitis C) Scheduled major abdominal surge... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005574-11 | Sponsor Protocol Number: Pennsaid-2014/P-3-01 | Start Date*: 2015-06-18 | |||||||||||
Sponsor Name:Nuvo Research GmbH | |||||||||||||
Full Title: A randomized, double-blind, multi-center, placebo-controlled, parallel group study to evaluate the efficacy and safety of an Diclofenac 2% (w/w) cutaneous solution applied twice daily in patients w... | |||||||||||||
Medical condition: Treatment of pain and Inflammation associated Acute Soft Tissue Injury/Ankle Sprain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003739-22 | Sponsor Protocol Number: GAL-01-2007 | Start Date*: 2007-10-04 | |||||||||||
Sponsor Name:GALSOR S.R.L. | |||||||||||||
Full Title: Safety and efficacy (for the symptom remission) of the treatment adjuvant of the antibiotic therapy of the acute episode of sinusitis (acute, subacute, chronic)with Ecballium Elaterium (SINUclean D... | |||||||||||||
Medical condition: Acute sinusitis or exacerbation of subacute or chronic sinusitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001119-19 | Sponsor Protocol Number: A0661206 | Start Date*: 2016-04-13 | ||||||||||||||||
Sponsor Name:Pfizer Inc. | ||||||||||||||||||
Full Title: Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/tonsillitis | ||||||||||||||||||
Medical condition: pharyngitis/tonsillitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022819-19 | Sponsor Protocol Number: P1001GF | Start Date*: 2010-12-10 | |||||||||||
Sponsor Name:G. Pohl-Boskamp GmbH & Co. KG | |||||||||||||
Full Title: Efficacy, safety and tolerability of two weeks treatment with SIA capsules in acute bronchitis - A multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial - | |||||||||||||
Medical condition: acute bronchitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000341-13 | Sponsor Protocol Number: OTV.PRE.01 | Start Date*: 2012-08-28 | ||||||||||||||||
Sponsor Name:Weber & Weber GmbH & Co. KG | ||||||||||||||||||
Full Title: Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Placebo Controlled, Randomized, Double-blinded Parallel-Grou... | ||||||||||||||||||
Medical condition: recurrent acute otitis media | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-013198-16 | Sponsor Protocol Number: FIMAVIC | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:UNIVERSITA` DEGLI STUDI DI PARMA | |||||||||||||
Full Title: Acute Myocardial Infarction and endothelial function. Assessment with a non invasive ultrasonographic computerized method during oral vitamin C supplementation. | |||||||||||||
Medical condition: Patients affected by non fatal new myocardial infarction (STEMI and N-STEMI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002313-18 | Sponsor Protocol Number: PAMORA-AP_2020 | Start Date*: 2020-12-22 | |||||||||||
Sponsor Name:Mech-Sense, Aalborg University Hospital | |||||||||||||
Full Title: The effects of opioid receptor antagonism on acute pancreatitis: An investigator initiated, randomized, placebo-controlled, double-blind clinical trial | |||||||||||||
Medical condition: Acute pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005602-10 | Sponsor Protocol Number: 1.1 | Start Date*: 2022-01-20 |
Sponsor Name:Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB) | ||
Full Title: POESIA Study: Pleiotropic effects of PCSK 9 inhibition and bempedoic acid - Changes in Platelet Function and Inflammation Markers | ||
Medical condition: platelet activity and inflammation markers in patients with coronary artery disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001435-63 | Sponsor Protocol Number: NACFL-ZI-L-01-06 | Start Date*: 2008-01-28 | |||||||||||
Sponsor Name:ZAMBON ITALIA | |||||||||||||
Full Title: AEROSOLIC TREATMENT OF ACUTE AND RECURRENT RHINOSINUSITIS DURING INTERCRITICAL STAGES : SINGLE BLIND CLINICAL STUDY, N-ACETYLCISTEIN VS AMBROXOL, ASSOCIATED WITH CORTISONE THERAPY | |||||||||||||
Medical condition: Patients with acute recurrent rhinosinusitis(intercritical stages) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.